Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More introductions for Collagen's Trilucent implant:

This article was originally published in Clinica

Executive Summary

Collagen (US) has launched its Trilucent breast implant in the Netherlands and Belgium. Since its introduction in the UK in September 1995, the soyabean oil filled implant has been launched in Germany, Spain, Austria and Switzerland. The company has also received US FDA approval to start a 400- patient trial of Trilucent at 30 US centres, and expects to commence trials within the next six months. Collagen hopes to submit an application for approval in two to four years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel